日日摸夜夜添夜夜添AV,国产午夜精品久久久久婷看片 ,91久久中文精品无码中文字幕

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
暫無牌價(jià)信息，您可以發(fā)送詢價(jià)，我們會(huì)盡快給你回復(fù)。

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

暫無牌價(jià)信息，您可以發(fā)送詢價(jià)，我們會(huì)盡快給你回復(fù)。

基本信息

英文名稱	Fedratinib \| TG-101348 \| SAR 302503
中文名稱	菲卓替尼
CAS號(hào)	936091-26-8
分子式	C27H36N6O3S
分子量	524.68
外觀	White to light yellow powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Fedratinib, also known as TG101348 and SAR302503, is a JAK2 inhibitor, is also an orally bioavailable, small-molecule, ATP-competitive inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity. JAK2 inhibitor TG101348 competes with JAK2 as well as the mutated form AK2V617F for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and the induction of tumor cell apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders (MPDs); the mutated form JAK2V617F has a valine-to-phenylalanine modification at position 617 and plays a key role in tumor cell proliferation and survival.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒有相關(guān)產(chǎn)品

瀏覽記錄

久久久无码视频,91亚洲福利视频,欧美黑人精品一区二区不卡,欧妇女乱妇女乱视频

菲卓替尼

Fedratinib | TG-101348 | SAR 302503

化學(xué)品安全說明書(MSDS)